Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
<p>Abstract</p> <p>Background</p> <p>Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA).</p> <p>...
Main Authors: | Rizzoli René, Delmas Pierre D, Burlet Nansa, Bruyère Olivier, Cooper Cyrus, Reginster Jean-Yves |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/9/165 |
Similar Items
-
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
by: Bruyere, Olivier, et al.
Published: (2008) -
SYMPTOMATIC SLOW ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS
by: L. I. Alekseeva
Published: (2012-04-01) -
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01) -
Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting
by: A. M. Lila, et al.
Published: (2019-10-01) -
European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Newsletter
by: RENE RIZZOLI, et al.
Published: (2007-08-01)